{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:47:56Z","timestamp":1788608876177,"version":"build-2803163510"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","annalspathology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.anndiagpath.2016.09.013","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T06:25:14Z","timestamp":1475130314000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"special_numbering":"C","title":["Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies"],"prefix":"10.1016","volume":"25","author":[{"given":"Khin","family":"Thway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Noujaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0005","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/01913120600820468","article-title":"Dermatofibroma and dermatofibrosarcoma protuberans: a comparative ultrastructural study","volume":"30","author":"Dominguez-Malagon","year":"2006","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0560.1979.tb01133.x","article-title":"Dermatofibrosarcoma protuberans. An ultrastructural study of five cases","volume":"6","author":"Zina","year":"1979","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaad.2006.09.006","article-title":"Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002","volume":"56","author":"Criscione","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ad.2011.12.005","article-title":"Dermatofibrosarcoma protuberans in childhood","volume":"103","author":"Valdivielso-Ramos","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000478-200301000-00004","article-title":"Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data\u2014a study from the French Federation of Cancer Centers Sarcoma Group","volume":"27","author":"Terrier-Lacombe","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0030","first-page":"375","article-title":"Dermatofibrosarcoma protuberans: from translocation to targeted therapy","volume":"12","author":"Noujaim","year":"2015","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.143.2.203","article-title":"A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans","volume":"143","author":"Maire","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0040","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00000478-199210000-00001","article-title":"Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas","volume":"16","author":"Connelly","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0045","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M","article-title":"Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution","volume":"88","author":"Bowne","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0050","first-page":"241","article-title":"Dermatofibrosarcoma protuberans: treatment and prognosis","volume":"18","author":"Rutgers","year":"1992","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejso.2003.12.005","article-title":"Outcomes of surgery for dermatofibrosarcoma protuberans","volume":"30","author":"Chang","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0060","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0190-9622(96)90597-6","article-title":"Dermatofibrosarcoma protuberans","volume":"35","author":"Gloster","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s12105-009-0160-z","article-title":"The impact of advances in molecular genetic pathology on the classification, diagnosis and treatment of selected soft tissue tumors of the head and neck","volume":"4","author":"Garcia","year":"2010","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/PAS.0b013e3181cf7fc1","article-title":"Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases","volume":"34","author":"Edelweiss","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/DAD.0b013e31817d32b2","article-title":"Dermatofibrosarcoma protuberans presenting as a subcutaneous mass: a clinicopathological study of 15 cases with exclusive or near-exclusive subcutaneous involvement","volume":"30","author":"Bague","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0080","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/PAS.0b013e31826b7919","article-title":"Primary intrathoracic dermatofibrosarcoma protuberans","volume":"36","author":"King","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3322\/canjclin.42.2.116","article-title":"Dermatofibrosarcoma protuberans","volume":"42","author":"Laskin","year":"1992","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0190-9622(89)70173-0","article-title":"Dermatofibrosarcoma protuberans of the scalp: a series of cases","volume":"21","author":"Rockley","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00000478-198804000-00005","article-title":"Fibrosarcomatous change in dermatofibrosarcoma protuberans","volume":"12","author":"Wrotnowski","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0100","doi-asserted-by":"crossref","first-page":"e1001","DOI":"10.1097\/MD.0000000000001001","article-title":"Dermatofibrosarcoma protuberans: computed tomography and magnetic resonance imaging findings","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0105","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1200\/JCO.2005.02.5122","article-title":"Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate","volume":"23","author":"Fiore","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0110","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cam4.288","article-title":"Epidemiology and survivorship of soft tissue sarcomas in adults: a national cancer database report","volume":"3","author":"Corey","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0115","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1245\/ASO.2003.03.581","article-title":"Dermatofibrosarcoma protuberans: reappraisal of wide local excision and impact of inadequate initial treatment","volume":"10","author":"Khatri","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0120","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00000478-200604000-00002","article-title":"The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans","volume":"30","author":"Abbott","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0125","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000478-200008000-00010","article-title":"Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up","volume":"24","author":"Goldblum","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1586\/14737140.2015.1052799","article-title":"Current treatment options for dermatofibrosarcoma protuberans","volume":"15","author":"Rutkowski","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0135","first-page":"5778","article-title":"Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis","volume":"61","author":"Sjoblom","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0140","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/ijc.1190","article-title":"Growth-inhibitory effect of STI571 on cells transformed by the COL1A1\/PDGFB rearrangement","volume":"92","author":"Greco","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.10535","article-title":"Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans","volume":"100","author":"Maki","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0150","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1200\/JCO.2002.01.027","article-title":"Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans","volume":"20","author":"Rubin","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0155","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1158\/1078-0432.CCR-13-1411","article-title":"Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up","volume":"20","author":"Ugurel","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0160","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1158\/1078-0432.CCR-09-3401","article-title":"Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients","volume":"16","author":"Kerob","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0165","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.2005.07.088","article-title":"Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225","volume":"23","author":"McArthur","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0170","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2009.25.7899","article-title":"Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials","volume":"28","author":"Rutkowski","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0175","first-page":"8288","article-title":"Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib","volume":"8","author":"Fu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2045-3329-3-5","article-title":"Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report","volume":"3","author":"Kamar","year":"2013","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-3083.2010.03774.x","article-title":"Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection","volume":"25","author":"Rutkowski","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0190","doi-asserted-by":"crossref","first-page":"959132","DOI":"10.1155\/2011\/959132","article-title":"Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans","volume":"2011","author":"Rutkowski","year":"2011","journal-title":"Sarcoma"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00001813-200504000-00014","article-title":"Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate","volume":"16","author":"Labropoulos","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.10202","article-title":"Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment","volume":"37","author":"Sirvent","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00428-009-0776-0","article-title":"Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations","volume":"456","author":"Fisher","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0210","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/modpathol.3800695","article-title":"Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans","volume":"19","author":"Abbott","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0165-4608(98)00183-6","article-title":"Dermatofibrosarcoma protuberans harboring t(9;22)(q32;q12.2)","volume":"110","author":"Sonobe","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0220","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.humpath.2007.06.009","volume":"39","author":"Patel","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0225","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0165-4608(01)00617-3","article-title":"Fusion of COL1A1 exon 29 with PDGFB exon 2 in a der(22)t(17;22) in a pediatric giant cell fibroblastoma with a pigmented Bednar tumor component. Evidence for age-related chromosomal pattern in dermatofibrosarcoma protuberans and related tumors","volume":"134","author":"Maire","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0230","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.onc.1202051","article-title":"Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans","volume":"17","author":"Greco","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0235","first-page":"3719","article-title":"The dermatofibrosarcoma protuberans-associated collagen type Ialpha1\/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB","volume":"59","author":"Shimizu","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0240","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/modpathol.3800783","article-title":"Detection of COL1A1-PDGFB fusion transcripts and PDGFB\/PDGFRB mRNA expression in dermatofibrosarcoma protuberans","volume":"20","author":"Takahira","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0245","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0250","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0255","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.humpath.2012.09.021","article-title":"PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications","volume":"44","author":"Ha","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0260","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.humpath.2010.07.015","article-title":"Identification of t(17;22)(q22;q13) (COL1A1\/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays","volume":"42","author":"Segura","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0265","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1200\/JCO.2007.14.7330","article-title":"Value of cytogenetic analysis in the treatment of dermatofibrosarcoma protuberans","volume":"26","author":"Kerob","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0270","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/gcc.20874","article-title":"Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase\u2013polymerase chain reaction and fluorescence in situ hybridization methodologies","volume":"50","author":"Salgado","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0275","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000056901","article-title":"Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans","volume":"92","author":"Kiuru-Kuhlefelt","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0280","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.humpath.2003.09.016","article-title":"Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans","volume":"35","author":"Takahira","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(02)00848-8","article-title":"Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma","volume":"140","author":"Sandberg","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0290","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0002-9440(10)63593-6","article-title":"Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans","volume":"163","author":"Linn","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0295","first-page":"262","article-title":"Overexpression of phosphorylated-STAT3 and phosphorylated-ERK protein in dermatofibrosarcoma protuberans","volume":"16","author":"Lin","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0300","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1684\/ejd.2011.1392","article-title":"The expression levels of thrombospondin-1 in dermatofibroma and dermatofibrosarcoma protuberans","volume":"21","author":"Maekawa","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00403-014-1452-z","article-title":"miR-205 down-regulation promotes proliferation of dermatofibrosarcoma protuberans tumor cells by regulating LRP-1 and ERK phosphorylation","volume":"306","author":"Kajihara","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0310","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00428-008-0580-2","article-title":"Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion","volume":"452","author":"Bianchini","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0315","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0560.1996.tb00774.x","article-title":"Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases","volume":"23","author":"Calonje","year":"1996","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0320","first-page":"179","article-title":"Myoid cells in the fibrosarcomatous variant of dermatofibrosarcoma protuberans. Are they neoplastic?","volume":"34","author":"Sanz-Trelles","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0325","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/DAD.0b013e318145413c","article-title":"Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases","volume":"29","author":"Mentzel","year":"2007","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0330","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00000478-198307000-00007","article-title":"Myxoid variant of dermatofibrosarcoma protuberans","volume":"7","author":"Frierson","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0335","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0b013e31802ff7e7","article-title":"Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases","volume":"31","author":"Reimann","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0340","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2559.1988.tb02094.x","article-title":"Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study","volume":"13","author":"Fletcher","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0345","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1091>3.0.CO;2-R","article-title":"Supernumerary ring chromosome in a Bednar tumor (pigmented dermatofibrosarcoma protuberans) is composed of interspersed sequences from chromosomes 17 and 22: a fluorescence in situ hybridization and comparative genomic hybridization analysis","volume":"30","author":"Nishio","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0350","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1097-0142(19891115)64:10<2154::AID-CNCR2820641030>3.0.CO;2-N","article-title":"Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans","volume":"64","author":"Shmookler","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00000372-200404000-00035","article-title":"Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy: an update","volume":"26","author":"Billings","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0360","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.anndiagpath.2006.12.010","article-title":"Giant cell fibroblastoma: an update and addition of 86 new cases from the armed forces Institute of Pathology, in honor of Dr. Franz M. Enzinger","volume":"11","author":"Jha","year":"2007","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0365","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/00000478-200207000-00013","article-title":"COL1A1-PDGFB gene fusion demonstrates a common histogenetic origin for dermatofibrosarcoma protuberans and its granular cell variant","volume":"26","author":"Maire","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0370","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2559.1990.tb00745.x","article-title":"Granular cell variant of dermatofibrosarcoma protuberans","volume":"17","author":"Banerjee","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0375","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2559.1995.tb00270.x","article-title":"Atrophic variants of dermatofibroma and dermatofibrosarcoma protuberans","volume":"26","author":"Zelger","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0380","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1046\/j.1365-2559.2000.01009.x","article-title":"Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases","volume":"37","author":"Llatjos","year":"2000","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0385","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/DAD.0b013e318234e704","article-title":"Vascular congenital dermatofibrosarcoma protuberans: a new histological variant of dermatofibrosarcoma protuberans","volume":"34","author":"Tantcheva-Poor","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0390","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000478-199805000-00009","article-title":"Fibrosarcomatous (\u201chigh-grade\u201d) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance","volume":"22","author":"Mentzel","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0395","first-page":"238","article-title":"CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans","volume":"119","author":"Goldblum","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0400","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/path.839","article-title":"Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans","volume":"194","author":"Sheng","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0405","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.2009.176","article-title":"D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans","volume":"23","author":"Bandarchi","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0410","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/modpathol.3800971","article-title":"Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans","volume":"21","author":"Lisovsky","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0415","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/01.pas.0000126857.86186.4c","article-title":"Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans","volume":"28","author":"West","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0420","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00000478-199407000-00002","article-title":"Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence","volume":"18","author":"Calonje","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0425","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/his.12377","article-title":"GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling","volume":"65","author":"Vivero","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0430","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1066896915627485","article-title":"The current status of solitary fibrous tumor: diagnostic features, variants, and genetics","volume":"24","author":"Thway","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0435","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/modpathol.2013.164","article-title":"Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics","volume":"27","author":"Doyle","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0440","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/PAS.0000000000000137","article-title":"STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors","volume":"38","author":"Yoshida","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0445","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAT.0000000000000122","article-title":"STAT6 rabbit monoclonal antibody is a robust diagnostic tool for the distinction of solitary fibrous tumour from its mimics","volume":"46","author":"Cheah","year":"2014","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0450","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/PAS.0b013e31825d532d","article-title":"Loss of retinoblastoma protein expression in spindle cell\/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications","volume":"36","author":"Chen","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0455","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1097\/00000478-200212000-00010","article-title":"Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics","volume":"26","author":"Folpe","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0460","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.humpath.2008.03.002","article-title":"GLUT-1 expression in mesenchymal tumors: an immunohistochemical study of 247 soft tissue and bone neoplasms","volume":"39","author":"Ahrens","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0465","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.anndiagpath.2013.10.007","article-title":"Malignant peripheral nerve sheath tumor: pathology and genetics","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0470","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.pas.0000213330.71745.39","article-title":"TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies","volume":"31","author":"Terry","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0475","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/modpathol.2009.47","article-title":"TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms","volume":"22","author":"Kosemehmetoglu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0480","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.anndiagpath.2014.09.002","article-title":"Synovial sarcoma: defining features and diagnostic evolution","volume":"18","author":"Thway","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0485","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1092-9134(98)80042-7","article-title":"Synovial sarcoma","volume":"2","author":"Fisher","year":"1998","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0490","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1066896915621967","article-title":"DOG1 expression in soft tissue tumors","volume":"24","author":"Ng","year":"2016","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2016.09.013_bb0495","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2559.2010.03624.x","article-title":"DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours","volume":"57","author":"Novelli","year":"2010","journal-title":"Histopathology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913416302647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T05:20:02Z","timestamp":1601097602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913416302647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":99,"alternative-id":["S1092913416302647"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.09.013","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}